Substandard and Falsified Medicines: Proposed Methods for Case Finding and Sentinel Surveillance

Autor: Elizabeth Pisani, Amalia Hasnida, Mawaddati Rahmi, Maarten Olivier Kok, Steven Harsono, Yusi Anggriani

Publikováno v: JMIR Public Health and Surveillance, Vol 7, Iss 8, p e29309 (2021)

The World Health Organization and others warn that substandard and falsified medicines harm health and waste money, especially in low- and middle-income countries. However, no country has measured the market-wide extent of the problem, and no standar

Externí odkaz: https://doaj.org/article/52cdf9aef1aa4fb5bd19c5c3e33faeb2

ANALISIS FAKTOR RISIKO PADA PASIEN HEMODIALISIS DI RS-X di JAKARTA

Autor: Prih Sarnianto, Yusi Anggriani, Mawaddati Rahmi

Publikováno v: PREPOTIF : JURNAL KESEHATAN MASYARAKAT; Vol. 5 No. 2 (2021): Oktober 2021; 1073-1083

Penyakit ginjal kronik (PGK) merupakan masalah kesehatan global dengan prevalensi dan biaya yang tinggi. Beberapa faktor pemicu PGK bersifat dapat dirubah, dengan harapan untuk menurunkan risiko terjadinya PGK, dan menurunkan tingkat keparahan PGK ya

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::832ec232c9dc4352f0bb0a84beeb483b
https://doi.org/10.31004/prepotif.v5i2.2392

Substandard and Falsified Medicines: Proposed Methods for Case Finding and Sentinel Surveillance (Preprint)

Autor: Mawaddati Rahmi, Steven Harsono, Amalia Hasnida, Elizabeth Pisani, Yusi Anggriani, Maarten Kok

UNSTRUCTURED The World Health Organization and others warn that substandard and falsified medicines harm health and waste money, especially in low- and middle-income countries. However, no country has measured the market-wide extent of the problem, a

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::ae8179e7c088a9fff52c03d2b698cdab
https://doi.org/10.2196/preprints.29309

Value for money of medicine sampling and quality testing: evidence from Indonesia.

Autor: Valente de Almeida S; Department of Infectious Disease Epidemiology, Imperial College London School of Public Health, London, UK svalente@ic.ac.uk., Hauck K; Department of Infectious Disease Epidemiology, Imperial College London School of Public Health, London, UK., Njenga S; Nuffield Department of Population Health, University of Oxford, Oxford, UK., Nugrahani Y; Center for Pharmaceutical Policy, Management and Services Studies, Faculty of Pharmacy - Universitas Pancasila, Jakarta, Indonesia., Rahmawati A; Center for Pharmaceutical Policy, Management and Services Studies, Faculty of Pharmacy - Universitas Pancasila, Jakarta, Indonesia., Mawaddati R; Center for Pharmaceutical Policy, Management and Services Studies, Faculty of Pharmacy - Universitas Pancasila, Jakarta, Indonesia., Saputra S; Center for Pharmaceutical Policy, Management and Services Studies, Faculty of Pharmacy - Universitas Pancasila, Jakarta, Indonesia., Hasnida A; Erasmus School of Health Policy & Management, Erasmus University Rotterdam, Rotterdam, Netherlands., Pisani E; Erasmus School of Health Policy & Management, Erasmus University Rotterdam, Rotterdam, Netherlands.; Policy Institute, King's College London, London, UK., Anggriani Y; Center for Pharmaceutical Policy, Management and Services Studies, Faculty of Pharmacy - Universitas Pancasila, Jakarta, Indonesia., Gheorghe A; Department of Infectious Disease Epidemiology, Imperial College London School of Public Health, London, UK.

Publikováno v: BMJ global health [BMJ Glob Health] 2024 Sep 23; Vol. 9 (9). Date of Electronic Publication: 2024 Sep 23.